The directorate of Chad's health ministry that acts as the national medicines regulator. Under the 2000 pharmacy law the Minister of Health grants marketing authorisations after advice from a National Medicines Commission; a 2025 study by WHO and DGPML staff rated the regulatory system's maturity as low.
Law No. 024/PR/2000 on pharmacy, adopted by the National Assembly on 30 October 2000, requires every proprietary or generic medicine sold or given in Chad to hold a marketing authorisation from the Minister of Health, valid for five renewable years. The Minister decides within six months of an application after the opinion of the National Medicines Commission, a refusal must give reasons, and grants, suspensions and withdrawals are to be published by the Ministry. A medicine chosen in a public tender is authorised for the length of the tender. The coordinates are an approximate N'Djamena city point.
A 2025 study by WHO's Chad office and DGPML staff describes the General Directorate of Pharmacy, Medicines and Laboratories as playing the role of the national pharmaceutical regulatory authority, with a national drug commission in charge of approval and a committee of pharmacovigilance experts. The authors rate the maturity of the regulatory system as low (level 1 on a scale of 1 to 4) and note that the authority lacks autonomy and independence. They record that Chad has no medicines manufacturer, that public supply runs through a central purchasing centre (CPA) and 23 provincial supply pharmacies, and that a 2023 mapping counted 50 private pharmacies, 47 of them in N'Djamena. The directorate also issued the 2022 national list of essential medicines.
Every source this page cites, grouped by who published it. Grouping is read from the web address, not assigned by hand.
A source that has moved or gone is reported by the weekly link check. /audit/